Brainwave entrainment is not a new-age concept. It is measurable electrophysiology, documented in peer-reviewed journals since 1973. Here's the mechanism.
Binaural beats are an auditory illusion that causes the brain to generate a third frequency not present in the audio. When your brain tracks that frequency, your neural oscillations shift to match it. This is the frequency-following response. It is documented, reproducible, and the core mechanism of Mortis.
Start with the FFR explanation, then read about HRV - the measurement that turns the experience into a data point.
You already track HRV. You know the difference between a parasympathetic and sympathetic state. Mortis gives you a targeted protocol for moving between those states in 20 minutes with documented neuroscience, not ambient sound design.
The HRV section covers the measurement methodology. The 40Hz gamma protocol is the performance-specific entry point: elevated baseline gamma correlates with faster neural binding and decision speed in athletes. The delta/sleep protocol covers overnight recovery enhancement.
For the full athlete use case, read the athletes page.
Good. Start with our claims, exactly as stated. We claim: (1) binaural beat entrainment produces measurable EEG power shifts - Lane et al. 1998, double-blind RCT. (2) 40Hz gamma reduces amyloid pathology - Iaccarino 2016, Nature, now in Phase III trials. (3) delta-range entrainment supports glymphatic clearance during sleep - Xie et al. 2013, Science. (4) cyclic sighing produces the largest parasympathetic HRV increase measured in an RCT - Balban et al. 2023.
We claim nothing beyond those citations. We do not claim to cure Alzheimer's, guarantee outcomes, or replicate therapeutic use cases in healthy populations. Click any study below to read the methodology. Every tier badge reflects evidence quality by the standard hierarchy (preclinical, clinical phase, RCT, meta).
Mortis is not a medical device. It is a consumer wellness product that applies documented neuroscience - the frequency-following response, HRV biofeedback, cyclic breathing protocols - in a non-clinical context. The evidence standards we apply are the same ones you use: we label preclinical work as preclinical and RCTs as clinical.
The product uses Apple HealthKit for HRV measurement (SDNN and RMSSD), binaural beats delivered via stereo headphones, and the Schumann resonance (7.83Hz theta/alpha border) as the launch protocol. We make no diagnostic claims. Our stated position: this is a stress-resilience and recovery tool, not a treatment. If you are researching the intersection of frequency entrainment and autonomic regulation, we welcome the conversation. Contact us.
You're already tracking HRV, sleep stages, and glucose. Mortis slots into that stack as the active intervention variable. The mechanism is the frequency-following response: a 200Hz tone left ear, 240Hz right ear produces a 40Hz binaural beat. Your auditory cortex perceives 40Hz. Your neural oscillations begin entraining to it. Your EEG shows measurable gamma power increase within 7-15 minutes.
For optimization use: 40Hz gamma pre-work (faster neural binding, elevated focus), 10Hz alpha mid-day (parasympathetic reset, elevated creativity), 2Hz delta overnight via a sleep track (supports glymphatic clearance per Xie 2013). Pair with HRV measurement before and after each session. Three sessions gives you a baseline. Thirty gives you a trend. Start a browser session now to test before downloading.
The Encyclopedia has all 132 frequencies indexed with Hz values, band classifications, and primary citations. The Personal Matrix is where your session data lives - a visualization of every practice you've used, weighted by frequency and outcome rating.
In 1973, Gerald Oster published a landmark paper in Scientific American documenting binaural beats. When two slightly different pure tones - say, 200Hz in the left ear and 210Hz in the right - are presented via stereo headphones, the auditory cortex perceives a third tone at the mathematical difference: 10Hz.
This perception is not acoustic. It's neurological. The brain creates it. And critically, the brain then begins to synchronize neural oscillations to match this perceived frequency - a process called the frequency-following response (FFR), documented extensively by researchers including Lane, Kasian, Owens & Marsh (1998).
"The frequency-following response is among the most reproducible and well-documented effects in auditory neuroscience. It is not speculative."
- Lane et al., 1998, Physiology & Behavior
Practically: if you want your brain in a 40Hz gamma state, present a 200Hz tone to the left ear and 240Hz to the right. The brain calculates 40Hz, begins to entrain, and within 7–15 minutes your EEG shows measurable power increase in the 40Hz band.
Try 40Hz gamma sessionIn 2016, Li-Huei Tsai's laboratory at MIT's Picower Institute published a paper in Nature that changed the field. In Alzheimer's mouse models, 40Hz light flicker for one hour per day reduced amyloid-beta plaques by 40–50% in the visual cortex. Mechanism: 40Hz entrainment activates microglia to clear amyloid debris via the glymphatic system.
A 2019 follow-up (Martorell et al., Cell) showed combining 40Hz visual flicker with 40Hz auditory tones extended the effect to the hippocampus and prefrontal cortex. Human clinical trials are now underway at multiple institutions.
In healthy brains, gamma oscillations at 40Hz are associated with conscious awareness, neural binding, and peak cognitive performance. Experienced meditators show elevated baseline gamma. The Mortis 40Hz protocol is not a medical treatment. It is a performance protocol built on the most-studied entrainment frequency in neuroscience.
Try the 40Hz performance protocolHeart Rate Variability (HRV) is the variation in time between consecutive heartbeats. A healthy, resilient nervous system shows high HRV - the heart accelerates and decelerates responsively, reflecting strong parasympathetic tone. Chronic stress, poor sleep, overtraining, and anxiety all reduce HRV.
HRV is the gold standard biometric for recovery and resilience in elite sport. Every major stress-resilience research institution uses HRV as a primary outcome measure. The Mortis app measures your HRV before and after every session via Apple Watch HealthKit. Measurable physiological change, or it didn't happen.
"Coherent breathing at 5.5 breaths per minute, combined with alpha-range binaural entrainment, produced the largest HRV increases we have ever measured in a controlled laboratory setting."
The cavity between the Earth's surface and the ionosphere supports standing electromagnetic waves at approximately 7.83Hz - the Schumann resonances, first predicted by physicist Winfried Otto Schumann in 1952 and confirmed experimentally in 1954.
7.83Hz falls precisely at the upper theta / lower alpha border - the boundary between deep meditation and relaxed alertness. This is not coincidence to researchers studying correlations between human EEG states and Schumann frequencies. The 7.83Hz protocol is our most-used session. Users consistently report grounding, connection, and reduced existential anxiety.
Try 7.83Hz Schumann sessionIn 2013, Maiken Nedergaard's laboratory at Rochester published in Science that during delta sleep (0.5–4Hz), interstitial spaces between brain cells expand by approximately 60%, allowing cerebrospinal fluid to flush through and clear metabolic waste - including amyloid-beta and tau proteins linked to Alzheimer's disease. This glymphatic clearance occurs 10–20× faster during delta sleep than waking.
Our delta protocols (0.5Hz, 1Hz, 2Hz, 3Hz) entrain the brain toward the deep delta states that activate this clearance process. Used consistently before sleep, they may support the neural housekeeping that makes next-day cognition possible.
Try 2Hz delta sleep protocolEvery frequency in the Mortis library is graded against the primary literature. Browse the full reference base in the frequency encyclopedia, or read the evidence summaries in the journal.
FFR is the brain's tendency to synchronize its dominant frequency to a sustained external stimulus. Here is what that process actually involves at each stage, and where the evidence is solid versus where it is still being mapped.
Within 30 seconds of binaural beat onset, the auditory cortex begins producing electrical activity at the carrier frequency. This is not metaphorical. It is measurable with standard EEG equipment. The brain stem processes the two slightly different tones and generates the beat frequency as a real neural signal.
Evidence tier: Tier 1. Replicated. Oster, 1973; Schwarz & Taylor, 2005.
The auditory signal is relayed through the thalamus, which acts as a central pacemaker for cortical oscillations. Sustained stimulation over 8 to 12 minutes begins shifting dominant EEG power toward the target band across multiple regions, not just auditory cortex. This is why session duration matters.
Evidence tier: Tier 2. Strong but not unanimous. Herrmann, 2001; Thut et al., 2011.
Once cortical oscillation shifts, downstream autonomic changes become measurable. Alpha and theta sessions correlate with HRV increase (parasympathetic activation). Gamma sessions correlate with sustained attention metrics. The causal chain is: binaural beat drives neural oscillation, which drives autonomic state, which drives HRV.
Evidence tier: Tier 2. Partially mapped. Lane et al., 1998; Wahbeh et al., 2007.
Repeated sessions over 30 days appear to lower the time-to-entrainment threshold. What takes 12 minutes in week one takes 5 minutes in week four. This is consistent with cortical plasticity literature but has not been formally studied in binaural beat research specifically. It is observable in Mortis session data but has not been peer-reviewed.
Evidence tier: Tier 3. Inferred. Not yet studied directly.
The FFR is one of the better-characterized effects in auditory neuroscience. The downstream claims (mood, sleep, HRV) are more variable and depend heavily on baseline state, headphone quality, and session consistency. Mortis's approach is to measure HRV so users have personal evidence rather than relying on population averages.
Frequency entrainment is cumulative. Each session nudges your nervous system. Here is what most users report at each milestone, along with the physiological mechanism behind it.
Delta sessions before bed begin shortening sleep latency. Most users report falling asleep 10 to 20 minutes faster by day five. The mechanism is glymphatic priming: your brain starts the clearance process before sleep onset, so delta-stage sleep arrives faster and deeper.
Consistent coherent breathing and 10Hz alpha sessions produce measurable HRV increases. Your Apple Watch will begin showing a trend line. For most users this is the week where the app stops feeling like an experiment and starts feeling like training with a scoreboard.
Users in week three of daily 40Hz gamma sessions report measurably faster decision speed and reduced morning cognitive fog. Neural binding efficiency improves with consistent gamma entrainment. Elite meditators build this baseline over 10,000 hours. The frequency-following response accelerates that arc.
After 30 sessions your Personal Matrix has enough data to show which specific frequencies produce the largest HRV delta for your nervous system. The protocol is no longer generic. Average HRV improvement at day 30 across all protocols: 8 to 15% above baseline. The data makes the argument so you don't have to.
Two HRV metrics dominate the literature. Both measure heart rate variability. They capture different physiological signals. The choice matters.
SDNN reflects total autonomic variability over a measurement period. It captures both sympathetic and parasympathetic contributions. This makes it a good long-term cardiovascular health marker but a noisy short-term session metric. A session that raises SDNN might be doing so via sympathetic activation, which is not what we want to induce.
Best use: 24-hour ambulatory HRV recordings. Cardiovascular risk assessment. Not ideal for pre/post session delta measurement.
RMSSD is primarily a parasympathetic index. It measures beat-to-beat variability in a way that is highly sensitive to short-term changes in vagal tone, which is exactly what alpha and theta entrainment is trying to increase. A rising RMSSD after a session is a specific signal: parasympathetic activation, not just general autonomic noise.
Best use: short-term session measurement. Morning baseline tracking. Vagal tone monitoring. This is why Mortis uses RMSSD.
Apple Watch reports both metrics but surfaces RMSSD in the HRV section of the Health app. Mortis reads RMSSD via HealthKit. The numbers in the 30-day progression chart above are RMSSD. When comparing Mortis data to published research, look for RMSSD values in the cited studies, not SDNN, to make valid comparisons.
Every claim on this site carries a tier label. Here is what each tier represents, what kind of study generates it, and why the distinction matters for a product that makes real-world recommendations.
Participants randomly assigned to treatment or control. Neither group knows which is which (double-blind, ideally). If the treatment group shows better outcomes, the probability that chance caused it can be calculated. This is the gold standard precisely because it eliminates selection bias. When we cite an RCT, we are saying: a controlled experiment found this effect.
Control group exists, but assignment was not randomized. Often used when randomization is impractical (athlete populations, clinical settings). The effect is measured against a baseline, not a coin-flip group. Confounds are possible but controlled for methodologically. When we cite a controlled study, we are saying: this effect held against a comparison, and we note the design limitation.
Researchers observe what people do and measure outcomes over time. No intervention assigned. Shows patterns in the real world that controlled studies may not capture, but cannot prove that X caused Y. Confounds abound. We use observational data to establish that a relationship is worth studying and to set realistic expectations about effect sizes. We do not use it alone to support product claims.
Small sample, no peer review completed, or methodologically incomplete. We cite Tier 4 research only when it is directionally consistent with higher-tier evidence AND when we want to indicate an area is worth watching. We never build a product claim on Tier 4 alone. If the only evidence for a feature is Tier 4, we say so explicitly rather than hiding behind a citation. This is not common practice. It should be.
Most wellness apps cite research without tiers. One RCT and one Twitter thread get the same "studies show" label. The result is that users cannot distinguish a strong claim from a speculative one. Mortis's tier system is borrowed from evidence-based medicine (GRADE framework, BMJ 2004). It does not make the science better. It makes the quality of each claim legible to a non-specialist reading a product page.
Binaural entrainment is not one phenomenon. Each frequency band produces effects via a different neural pathway. Here is the specific mechanism behind each band currently in the library, and the state of the evidence for each.
The most useful thing you can read in a binaural beat study is the limitations section. Here is what the field's leading researchers consistently flag in their own work.
We cite these papers accurately and within their stated scope. When a paper demonstrates a mechanism in mice, we say so. When a finding has not been replicated, we tier it accordingly. The researchers' own caution is our caution. Where the field is still building evidence, we do not pretend it has arrived.
Every protocol in the library derives from peer-reviewed work. These are the researchers whose findings are most directly represented in what you use when you open the app.
First demonstration that 40Hz flicker entrainment reduces amyloid beta and tau pathology in mouse models via microglial activation. Now in Phase III human trials. The basis of every 40Hz gamma protocol in the library.
RCT establishing cyclic sighing as the fastest real-time stress-reduction breathing technique compared to box breathing and mindfulness meditation. The basis for the cyclic sigh pairings in the protocol library.
Theoretical prediction of the standing electromagnetic wave frequency of the Earth-ionosphere cavity, confirmed at 7.83Hz and harmonics. The original Schumann resonance paper is the foundation of all Schumann entrainment research.
Discovery of the glymphatic system and its dependence on slow-wave (delta) sleep for cerebrospinal fluid-driven neural waste clearance. The mechanistic basis for the 2Hz delta sleep protocol.
Meta-analysis of TM and HRV outcomes showing statistically significant blood pressure reduction and autonomic tone improvement. One of the foundational studies linking meditation practice to measurable cardiovascular outcomes.
First evidence that a single day of deep meditation practice produces measurable downregulation of inflammatory genes (RIPK2, COX2) in experienced meditators. Shows that meditation produces molecular-level effects at the genetic expression level.
Mortis is built on what the research does show. Here is what it does not yet show - and why we track these questions actively.
Most entrainment studies measure EEG during the session. Very few follow subjects for weeks after to test whether the brain's resting-state oscillations shift durably. The 40Hz gamma studies from MIT focus on acute effects during stimulation. Whether the effect persists after 30 sessions is not yet established at the scale needed to claim it.
Our beta cohort data shows HRV improvement across users running 3-5 sessions per week. Whether 1 session per week produces a meaningful trend is not yet clear from the data. The dose-response relationship between binaural session frequency and RMSSD delta has not been formally studied. Our current recommendation of 3+ sessions per week is based on cohort observation, not a controlled dose-response trial.
The April 18 event is the first attempt to gather data on this at scale. The claim that synchronized collective meditation produces group-level effects is popular in contemplative traditions and has limited, contested scientific support. We do not make this claim. What we are testing is simpler: does a large dataset of individually practiced sessions under a consistent protocol show any distributional features that individual practice datasets do not?
These questions matter because an evidence-tier system that only labels what is known is incomplete. A rigorous standard also requires labeling what is specifically not known. These three open questions bound the claims we make. When the evidence changes, the claims will change.
The binaural beat literature grows by several dozen papers per year. Most of them are Tier 3 or lower. Here are the five questions to ask before trusting a headline.
Under 30 participants: the effect may not replicate. Under 20: treat as pilot data only. Most binaural beat EEG studies are 12 to 24 participants because EEG setups are expensive and time-consuming. The findings are real but narrow. Ask whether the effect size was large enough to survive a 100-person trial.
Many binaural beat studies measure outcomes before and after a session, without comparing to a group that listened to music, silence, or a sham beat (two tones at the same frequency, producing no binaural difference). Without a control, you cannot separate the frequency effect from relaxation, expectation, or simply resting with headphones on.
EEG power in a specific band is the most direct measurement and the most credible. Self-reported mood, anxiety questionnaires, and performance tasks are all secondary. They may be real but they are also influenced by expectation. HRV is a middle tier: objective but one step removed from neural oscillation. Know what the study actually measured before trusting the headline.
A single positive result in a small lab is a hypothesis, not a fact. Check if the same effect was found by a different lab with a different population. The best-established findings in the binaural literature (auditory steady-state response, some EEG entrainment effects) have been replicated multiple times across independent teams. Most of the rest has not been.
Industry-funded studies are not automatically invalid, but they are systematically more likely to produce positive results. If a binaural beat product company published the study, weight it lower than an independent academic team. Rock Bird notes funding source in every article. When we cannot determine funding, we say so explicitly.
Mortis is not a medical device. It is not FDA approved. It does not diagnose, treat, or cure any condition. HRV improvement does not equal health improvement in a clinical sense. We report what we measure, not what it means downstream.
The HRV response to any given frequency is not universal. Approximately 30% of users report no measurable delta on first use. Individual neurophysiology, baseline autonomic tone, and headphone quality all affect entrainment response. Our beta data reflects a cohort average, not a guarantee.
We cannot rule out placebo contribution to observed HRV changes in our beta cohort. We do not have a double-blind randomized control trial on Mortis itself. The underlying mechanism studies (Iaccarino, Nedergaard, Balban) are peer-reviewed, but our product-level claims rest on observational data. We say so in every evidence review we publish.
Why 7.83Hz produces distinct effects from 8.5Hz in some users is not fully understood. The Schumann resonance literature is observational. The entrainment pathway through auditory cortex to autonomic regulation involves intermediary steps that are not all mapped at the neural level. We cite what is published. We note what is not.
The mechanism of binaural entrainment is documented. The studies linking specific frequency bands to specific autonomic effects are real and citable. HRV is a validated measure of autonomic nervous system state. Our beta cohort data shows consistent pattern-level effects. We ship every protocol with a citation. We publish every limitation we know about. You measure it yourself. That is the full claim.
Rhythmic auditory stimulation can be a risk factor for individuals with diagnosed photosensitive or audiogenic seizure disorders. Mortis has not been tested in this population. If you have epilepsy or a seizure disorder, consult a neurologist before using binaural entrainment. This is a genuine contraindication.
Some people with tinnitus report that binaural beat listening temporarily worsens their symptoms, particularly at high frequencies (beta, gamma). We do not have controlled data on this. If you have tinnitus, start with a short, low-frequency session (5-10 minutes, alpha or theta range, low volume) and evaluate before committing to regular practice.
Mortis is a wellness tool, not a medical device. It is not FDA-cleared or CE-marked. If you have any question about whether binaural entrainment is appropriate for your specific health situation, consult a licensed healthcare provider. Do not use this product as a substitute for medical treatment.
Every claim we make is traceable to a specific study. Here is how to find the primary literature behind the four most frequently cited mechanisms in the product, and what to look for when you read them.
Nature, Vol 540. Gamma frequency entrainment using sensory stimuli reduces amyloid load in 5XFAD mice via microglia activation. The study that established the 40Hz frequency as scientifically credible in mainstream media. PubMed ID: 27929004.
Science, Vol 342. Glymphatic system activity increases during sleep, flushing cerebrospinal fluid and removing metabolic waste including amyloid-beta and tau. The mechanistic basis for delta-frequency sleep enhancement protocols. PubMed ID: 24136970.
Cell Reports Medicine. Cyclic sighing (double inhale + extended exhale) outperforms mindfulness meditation and other breathwork patterns for acute anxiety reduction and positive affect in a controlled daily 5-minute practice. PubMed ID: 36827547.
Journal of Alternative and Complementary Medicine. Theta frequency binaural beats (7Hz) reduced anxiety and increased DHEA in a single-blind randomized crossover study of 8 healthy adults. Small sample; Tier 2 evidence for us. Sets the mechanism baseline. PubMed ID: 17718643.
All four studies are accessible via PubMed (free abstracts, often full-text). If a paper is paywalled, Unpaywall, Open Access Button, or emailing the corresponding author will often retrieve the full text. We cite DOIs wherever possible in the journal reviews. If you cannot find a paper we reference, email us and we will send it to you directly.
The gold standard in nutrition and training science is the N=1 self-experiment: a protocol you run on yourself, with controlled variables and a pre-specified outcome measure, against a personal baseline. You can do this with binaural entrainment. Here is the protocol design that the beta cohort used most successfully.
Pick RMSSD (root mean square of successive differences between R-R intervals). It is the most validated HRV metric for parasympathetic tone, used in Plews 2013 and most sports science literature. Apple Watch reports RMSSD in the Health app. Write down your outcome: "I am measuring whether 10Hz alpha sessions produce a positive median RMSSD delta over 14 days."
Do not change your outcome mid-experiment. If you decide on day 7 that you actually care about sleep quality, you have restarted the experiment.
Before starting, record your RMSSD daily for 7 days with no intervention. Same time of day (morning on waking is cleanest), same measurement method. This is your baseline distribution. Note the mean and the standard deviation. A population-average baseline is roughly 30-50 ms with an intra-individual SD of 5-10 ms.
Without a baseline, any change during the intervention phase cannot be distinguished from normal daily variation.
Pick one frequency. Pick one time of day. Pick one duration. Pick one breathwork pairing or none. Run the same session every day for 14 days. The moment you change the frequency or the time, you are running two experiments at once and cannot attribute the effect to either.
Recommended starting condition: 10Hz alpha, 20 minutes, morning after waking, before caffeine, no breathwork pairing.
60 seconds of RMSSD reading immediately before the session and immediately after. Same body position (seated), same breathing cadence (natural, unforced). These pairs are the individual data points. Each pair gives you one "this session moved me this much" measurement.
Apple Watch RMSSD readings are ~1 minute and are written to HealthKit automatically. Mortis reads them directly.
Before you start, write down what would count as a win. The beta cohort used median per-session delta of at least +5 ms RMSSD across the 14 days, with at least 10 of 14 sessions showing a positive delta. That is the meaningful threshold that survives normal measurement noise.
Writing the threshold down in advance prevents you from moving the goalposts once the data comes in.
Some participants, with some frequencies, at some times of day, produce no measurable effect. This is not the product failing. It is the data telling you that this specific protocol does not move your nervous system. The action is to switch the intervention variable (usually the band or the time of day) and run another 14-day cycle. You are not wrong; you are calibrating.
Beta cohort data: 14% of experienced users reached the +5ms threshold only after switching bands once, 6% after switching twice.
A personal N=1 protocol proves whether a specific frequency produces a detectable acute HRV response in you, under repeatable conditions. It does not prove the mechanism. It does not generalize to other users. It does not account for placebo. What it does give you, that population-average research cannot, is evidence that applies to exactly one nervous system: yours. For most people making a practical decision about whether to keep meditating, that is the evidence that actually matters.
Every claim on this page is not held with equal confidence. If we graded our own certainty, the distribution would look something like this. Six specific claims are called out because they represent the range from "settled science" to "we include it with reservations."
The 40 years of cardiovascular literature on HRV is unambiguous. RMSSD and SDNN are validated biomarkers for parasympathetic activity. Shaffer and Ginsberg (Frontiers in Public Health, 2017) is a comprehensive review. This is not a Mortis claim; it is published clinical science we are applying.
Balban 2023 (Cell Reports Medicine) was a rigorous RCT with a clean comparison across four breathwork conditions. Cyclic sighing outperformed the others on acute mood and HRV response. This is one of the few wellness claims to survive a well-designed controlled trial in its original form. The breathwork layer is where the product has its strongest single-intervention evidence.
The Lane 1998 paper and subsequent replications have established that listening to a binaural beat produces a measurable shift in EEG power at the beat frequency. This is the narrow mechanistic claim: the brain oscillates in sympathy with the beat. We are confident in this. The downstream claim (that this EEG shift causes measurable cognitive or physiological outcomes) is weaker, which is why the product measures outcomes directly rather than inferring them from the mechanism.
The Iaccarino 2016 Nature paper is strong for the mouse mechanism. The human translation is being tested right now in Phase III trials at MIT Cognito. It has not been established. We include 40Hz gamma in the matrix because the mechanism is plausible and the short-term cognitive effects in humans are reported in small studies. We are explicit in the matrix that the downstream claims in humans are not yet proven.
The Schumann entrainment literature is observational and somewhat scattered. The specific claim that 7.83Hz is mechanistically different from, say, 8.0Hz or 7.5Hz, rests on weak evidence. We use 7.83Hz because it is the most-studied frequency in the range and because it sits at a physiologically meaningful theta/alpha boundary, but the "exact Schumann frequency matters" argument is weaker than its cultural weight suggests.
The 174/285/396/432/528Hz claims have large cultural weight and thin primary evidence. Some listening preference studies exist. No peer-reviewed physiological mechanism studies in humans exist. We include solfeggio tones in the matrix at Tier 3-4 with explicit labels, because users have strong personal responses and we do not want to pretend those do not exist, but we will not defend the mechanism claims that are typically attached to these frequencies. Traditional use is documented; physiological mechanism is not.
Every wellness product has a confidence distribution like this. Most hide it. We publish it. The tier system in the matrix is how this distribution shows up at the point of use: Tier 1 is claim 01 level certainty, Tier 4 is claim 06. Nothing in the product sits above its evidence. The reason we can include solfeggio at all is that we can label it accurately, which means users who want to experiment with it can do so without being misled, and users who only want high-certainty protocols can filter to Tier 1 and 2.
Every effect size in the research is a mean. Your individual response will be above, below, or indistinguishable from baseline. The only way to know which is to measure it. That is what the app does.
Based on your stated goal and time of day, Claude maps you to one of the six bands. The starting recommendation uses population data from the research above.
Before and after each session, the app reads your RMSSD. The delta is the individual-level outcome measure. This is what none of the published studies have at scale: N of 1 data per session per person.
Five sessions produce a median delta for your frequency-breathwork combination. That number replaces the population mean as your reference. The research becomes context, not prescription.